J.J. Grau

691 total citations
14 papers, 543 citations indexed

About

J.J. Grau is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J.J. Grau has authored 14 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in J.J. Grau's work include Colorectal Cancer Treatments and Studies (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Metastasis and carcinoma case studies (2 papers). J.J. Grau is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Metastasis and carcinoma case studies (2 papers). J.J. Grau collaborates with scholars based in Spain, United States and France. J.J. Grau's co-authors include Jean Philippe Metges, Constantino Fondevila, Josep Fuster, Antonio Palacı́n, Manuel Pera, A Volant, Antoni Castells, Xavier Filella, E. Astudillo and Rafael Molina and has published in prestigious journals such as Annals of Surgery, British Journal of Cancer and Annals of Oncology.

In The Last Decade

J.J. Grau

14 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.J. Grau Spain	9	312	216	152	112	75	14	543
H.A. Phillips United Kingdom	10	228 0.7×	107 0.5×	158 1.0×	62 0.6×	58 0.8×	16	396
Holger G. Hass Germany	13	384 1.2×	208 1.0×	162 1.1×	115 1.0×	14 0.2×	40	644
S. Pugh United Kingdom	14	260 0.8×	98 0.5×	144 0.9×	88 0.8×	27 0.4×	36	506
Derrick S. Haslem United States	9	208 0.7×	154 0.7×	96 0.6×	54 0.5×	15 0.2×	30	459
Shelly S. Lo United States	10	286 0.9×	105 0.5×	64 0.4×	133 1.2×	21 0.3×	37	591
Brooke Vuong United States	11	365 1.2×	166 0.8×	237 1.6×	52 0.5×	38 0.5×	38	555
Clarence Wong Canada	15	253 0.8×	222 1.0×	329 2.2×	66 0.6×	14 0.2×	45	638
Charlotte Cohen France	12	198 0.6×	222 1.0×	56 0.4×	72 0.6×	29 0.4×	31	444
Elvira L. Vos United States	15	135 0.4×	165 0.8×	294 1.9×	62 0.6×	73 1.0×	36	569
Anne T. OʼMeara United States	11	236 0.8×	155 0.7×	103 0.7×	78 0.7×	10 0.1×	15	575

Countries citing papers authored by J.J. Grau

Since Specialization

Citations

This map shows the geographic impact of J.J. Grau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Grau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Grau more than expected).

Fields of papers citing papers by J.J. Grau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Grau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Grau. The network helps show where J.J. Grau may publish in the future.

Co-authorship network of co-authors of J.J. Grau

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Grau. A scholar is included among the top collaborators of J.J. Grau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Grau. J.J. Grau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cubero, Jorge Hernando, Alberto Carmona‐Bayonas, L. Iglesias, et al.. (2019). Durvalumab plus tremelimumab for the treatment of patients (pts) with refractory and progressive advanced thyroid carcinoma: A phase II multicohort trial (DUTHY / GETNE T1812). Annals of Oncology. 30. v759–v759. 4 indexed citations

Gómez, Ruth Gabriela Herrera, Laura Mezquita, Édouard Auclin, et al.. (2019). The head and neck lung immune prognostic index (HN-LIPI): A prognostic score for immune checkpoint inhibitors (ICI) in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients. Annals of Oncology. 30. v469–v470. 3 indexed citations

Caballero, Miguel, et al.. (2009). El papel de la quimioterapia en el cáncer de la cavidad oral avanzado. Acta Otorrinolaringológica Española. 60(4). 260–267. 1 indexed citations

Domingo‐Domenech, Josep, Rafael Molina, T Castel, et al.. (2005). Serum Protein S-100 Predicts Clinical Outcome in Patients with Melanoma Treated with Adjuvant Interferon – Comparison with Tyrosinase RT-PCR. Oncology. 68(4-6). 341–349. 14 indexed citations

Fondevila, Constantino, Jean Philippe Metges, Josep Fuster, et al.. (2004). p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. British Journal of Cancer. 90(1). 206–215. 154 indexed citations

Estapé, Tania, et al.. (2003). Cancer knowledge among Spanish women participating in literacy schemes. Psycho-Oncology. 12(2). 194–197. 7 indexed citations

Viñolas, Núria, Rafael Molina, Francesc Casas, et al.. (1998). Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary report.. PubMed. 18(1B). 631–4. 33 indexed citations

Pons, Françesca, Sergi Vidal‐Sicart, Carles Conill, et al.. (1997). Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 24(10). 1210–1214. 60 indexed citations

Filella, Xavier, Rafael Molina, Juan Carlos García‐Valdecasas, et al.. (1994). Use of CA 19-9 in the Early Detection of Recurrences in Colorectal Cancer: Comparison with CEA. Tumor Biology. 15(1). 1–6. 32 indexed citations

10.

Filella, Xavier, R. Molina, J.M. Piqué, et al.. (1994). CEA as a prognostic factor in colorectal cancer.. PubMed. 14(2B). 705–8. 20 indexed citations

11.

Grau, J.J., et al.. (1993). Positive results of adjuvant mitomycin-C in resected gastric cancer: A randomised trial on 134 patients. European Journal of Cancer. 29(3). 340–342. 50 indexed citations

12.

Daniels, Michael J., et al.. (1992). Cancer diagnosis disclosure in a Spanish hospital. Annals of Oncology. 3(6). 451–454. 60 indexed citations

13.

Filella, Xavier, Rafael Molina, J.J. Grau, et al.. (1992). Prognostic Value of CA 19.9 Levels in Colorectal Cancer. Annals of Surgery. 216(1). 55–59. 103 indexed citations

14.

Vidal, Àngela, et al.. (1979). Analisis de 163 casos de cancer primitivo de pulmon. Archivos de Bronconeumología. 15(1). 7–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact